Congress targets counterfeit drugs
Counterfeit pharmaceuticals were a focus of the House and Senate this week, as legislation was introduced in both bodies and a House hearing highlighted another bill aimed at thwarting online sales of fake drugs
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: